Raising the standards of pharma social compliance
How pharmacovigilance leaders view the rise of social media and Its risk to adverse event detection. Our survey of compliance professionals, conducted in partnership with FiercePharma, explores how pharma brands weigh the risks of social media.
The risk in doing the right thing
An ebook on how to lead with purpose during an era of social disruption. This summary was produced following a talk given by Crisp CEO and Founder Adam Hildreth and author Rishad Tobaccowala following the 2020 PRovoke PR Summit.
Brands at risk
A recent surge in harmful digital chatter on social media is putting brands at risk. To help brands understand what is expected of them, we surveyed more than 1,000 consumers.
Adverse event reporting in a digital age
A practical guide to social media monitoring adverse events in the digital age for pharma professionals.
How customers react to a brand crisis
For the 2019 crisis impact report, we surveyed 2,000 U.S. and U.K. consumers to understand the effect of a crisis on brand value and the importance of a strategic response to maintain customer loyalty.